IL96043A0 - Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known - Google Patents

Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known

Info

Publication number
IL96043A0
IL96043A0 IL96043A IL9604390A IL96043A0 IL 96043 A0 IL96043 A0 IL 96043A0 IL 96043 A IL96043 A IL 96043A IL 9604390 A IL9604390 A IL 9604390A IL 96043 A0 IL96043 A0 IL 96043A0
Authority
IL
Israel
Prior art keywords
peptides
proteins
amino acid
acid sequence
nucleotide coding
Prior art date
Application number
IL96043A
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/708,001 external-priority patent/US4863857A/en
Application filed by Univ Texas filed Critical Univ Texas
Publication of IL96043A0 publication Critical patent/IL96043A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695—Corticotropin [ACTH]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/803—Physical recovery methods, e.g. chromatography, grinding

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)

Abstract

Antibody to a polypeptide is provided, in which the polypeptide is complementary to at least a portion of a peptide ligand and characterised by said antibody having an affinity for a receptor site at which the peptide ligand binds and transmits its hormonal effects.
IL96043A 1985-03-01 1990-10-17 Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known IL96043A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/708,001 US4863857A (en) 1985-03-01 1985-03-01 Polypeptide complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known
US06/829,709 US5077195A (en) 1985-03-01 1986-02-19 Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known and methods of design therefor

Publications (1)

Publication Number Publication Date
IL96043A0 true IL96043A0 (en) 1991-07-18

Family

ID=27108003

Family Applications (1)

Application Number Title Priority Date Filing Date
IL96043A IL96043A0 (en) 1985-03-01 1990-10-17 Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known

Country Status (18)

Country Link
US (2) US5077195A (en)
EP (2) EP0332225B1 (en)
JP (1) JPH07215999A (en)
KR (1) KR920002315B1 (en)
AT (2) ATE88572T1 (en)
AU (1) AU592781B2 (en)
BR (1) BR8606615A (en)
CA (1) CA1339606C (en)
DE (2) DE3688333T2 (en)
DK (1) DK521386A (en)
ES (3) ES8705919A1 (en)
FI (1) FI90255C (en)
GR (1) GR860576B (en)
IE (1) IE58837B1 (en)
IL (1) IL96043A0 (en)
NO (1) NO174971C (en)
PT (1) PT82132B (en)
WO (1) WO1986005208A1 (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0199801B1 (en) * 1984-10-29 1993-08-25 MICROGENICS CORPORATION (a Delaware corporation) Methods for protein binding enzyme complementation assays
DE3527568A1 (en) * 1985-08-01 1987-02-05 Bissendorf Peptide Gmbh SYNTHETIC PEPTIDE RECEPTORS, METHOD FOR THE PRODUCTION AND USE THEREOF
CA1297003C (en) * 1985-09-20 1992-03-10 Jack H. Nunberg Composition and method for treating animals
AU595597B2 (en) * 1986-02-19 1990-04-05 Triton Biosciences Inc. Peptides affecting blood pressure regulation
US4772684A (en) * 1987-01-20 1988-09-20 Triton Biosciences, Inc. Peptides affecting blood pressure regulation
EP0331184A3 (en) * 1988-03-04 1991-05-08 The Board Of Trustees Of The University Of Alabama For Its Division University Of Alabama In Birmingham Peptide equivalents of non-peptides and methods of design therefor
DE69033395D1 (en) * 1989-07-31 2000-01-20 Tecnogen Scpa Process for the identification and production of binding sites of interacting proteins
US5324512A (en) * 1990-12-26 1994-06-28 The Population Council [Gln']-luteinizing hormone releasing hormone conjugate of tetanus vaccine and its uses
JPH05262788A (en) * 1991-09-03 1993-10-12 Hitachi Chem Co Ltd Peptides, designing and production thereof, and determination of the bonding position of physiologically active peptide on the receptor
US5620675A (en) 1992-06-23 1997-04-15 Diatech, Inc. Radioactive peptides
US6017512A (en) * 1992-06-23 2000-01-25 Diatide, Inc. Radiolabeled peptides
JP3923515B2 (en) * 1993-10-07 2007-06-06 倉敷紡績株式会社 Endothelin activity inhibitor
US6051206A (en) * 1994-06-03 2000-04-18 Diatide, Inc Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses
IL115177A0 (en) * 1994-09-16 1995-12-31 Immunomedics Inc Phosphorus-32 labeling of antibodies for cancer therapy
US5523208A (en) * 1994-11-30 1996-06-04 The Board Of Trustees Of The University Of Kentucky Method to discover genetic coding regions for complementary interacting proteins by scanning DNA sequence data banks
DE69627333T2 (en) * 1995-06-26 2004-02-12 PerSeptive Biosystems, Inc., Framingham AUTOMATED, CONTINUOUS, MULTI-DIMENSIONAL, HIGH-SPEED, MOLECULAR SELECTION AND ANALYSIS
US5807552A (en) * 1995-08-04 1998-09-15 Board Of Regents, The University Of Texas System Compositions for conferring immunogenicity to a substance and uses thereof
AU756139B2 (en) * 1997-12-01 2003-01-02 Fang Fang Multivalent recombinant antibodies for treating HRV infections
DE19805334A1 (en) * 1998-02-11 1999-08-12 Otogene Biotechnologische Fors Process for the development of an active pharmaceutical ingredient
CA2350163A1 (en) * 1998-04-24 1999-11-04 Fang Fang Identifying peptide ligands of target proteins with target complementary library technology (tclt)
US20030035798A1 (en) * 2000-08-16 2003-02-20 Fang Fang Humanized antibodies
ATE411811T1 (en) * 1999-03-09 2008-11-15 Fornix Biosciences N V COMPLEMENTARY SYNTHETIC PEPTIDES AND THEIR USE IN OPHTHALMOLOGY
GB2356401A (en) * 1999-11-19 2001-05-23 Proteom Ltd Method for manipulating protein or DNA sequence data
GB9929469D0 (en) * 1999-12-13 2000-02-09 Proteom Ltd Complementary peptide ligands generated from plant genomes
GB9929464D0 (en) * 1999-12-13 2000-02-09 Proteom Ltd Complementary peptide ligande generated from the human genome
GB9929466D0 (en) * 1999-12-13 2000-02-09 Proteom Ltd Complementary peptide ligands generated from microbial genome sequences
WO2002027313A1 (en) * 2000-09-26 2002-04-04 Geneformatics, Inc. Methods for determining aproximations of three dimensional polypeptide structure
GB0025251D0 (en) * 2000-10-14 2000-11-29 Proteom Ltd Antisense peptides to Fc receptors and their uses
EP1362093B1 (en) * 2001-02-20 2010-11-17 University Of Georgia Research Foundation, Inc. Rapid production of monoclonal antibodies
JP2005522192A (en) * 2001-07-19 2005-07-28 パーラン セラピューティクス， インコーポレイテッド Multimeric proteins and methods of making and using multimeric proteins
RU2519210C2 (en) * 2007-06-14 2014-06-10 Дзе Борд Оф Риджентс Фор Оклахома Стейт Юниверсити Vaccines containing genetic variants of canine parvovirus
US8227583B2 (en) * 2007-06-14 2012-07-24 The Board Of Regents For Oklahoma State University Vaccines containing canine parvovirus genetic variants
US20190062373A1 (en) * 2017-08-30 2019-02-28 Peption, LLC Method of generating interacting peptides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936694B1 (en) * 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes

Also Published As

Publication number Publication date
JPH07215999A (en) 1995-08-15
DE3679017D1 (en) 1991-06-06
CA1339606C (en) 1997-12-30
GR860576B (en) 1986-07-01
DE3688333D1 (en) 1993-05-27
US5077195A (en) 1991-12-31
ES552534A0 (en) 1987-05-16
FI90255B (en) 1993-09-30
EP0214232A1 (en) 1987-03-18
PT82132B (en) 1989-05-31
DE3688333T2 (en) 1993-10-28
ATE88572T1 (en) 1993-05-15
EP0214232B1 (en) 1991-05-02
AU5510286A (en) 1986-09-24
FI90255C (en) 1994-01-10
DK521386D0 (en) 1986-10-31
US5212072A (en) 1993-05-18
WO1986005208A1 (en) 1986-09-12
EP0332225A2 (en) 1989-09-13
AU592781B2 (en) 1990-01-25
NO864369L (en) 1987-01-02
EP0332225A3 (en) 1989-09-27
ES557189A0 (en) 1987-11-01
IE860527L (en) 1986-09-01
ES8800266A1 (en) 1987-11-01
IE58837B1 (en) 1993-11-17
KR870700100A (en) 1987-02-28
ES8705919A1 (en) 1987-05-16
BR8606615A (en) 1987-08-11
NO174971C (en) 1994-08-10
DK521386A (en) 1986-12-29
PT82132A (en) 1986-04-01
EP0332225B1 (en) 1993-04-21
FI864427A0 (en) 1986-10-30
ATE63138T1 (en) 1991-05-15
KR920002315B1 (en) 1992-03-21
ES557188A0 (en) 1987-11-01
ES8800267A1 (en) 1987-11-01
FI864427A (en) 1986-10-30
NO174971B (en) 1994-05-02
NO864369D0 (en) 1986-10-31

Similar Documents

Publication Publication Date Title
IL96043A0 (en) Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known
DE3856560D1 (en) DNA SEGMENTS, POLYPEPTIDES AND ANTIBODIES SIMILAR TO HUMAN TISSUE FACTOR
SI1642972T1 (en) Therapeutic uses of BR43X2 soluble receptors
GB2183661B (en) Method for obtaining dna, rna, peptides, polypeptides or proteins by means of a dna recombinant technique
IL89541A0 (en) Urethane-protected amino acid-n-carboxyanhydrides and their use in the synthesis of polypeptides
HK1008021A1 (en) Growth hormone receptor
EP0150735A3 (en) Method and composition for preparation of factor viiic
DE69033453D1 (en) Recombinant polypeptides and peptides, nucleic acids coding therefor and their use in tuberculosis diagnosis
ES2184728T3 (en) FIBRONECTINE UNION PROTEINS.
ZA861482B (en) Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known
GR3035099T3 (en) Corpuscles of stannius protein, stanniocalcin
CA2021722A1 (en) Variant proteins and polypeptides possessing enhanced affinity for immobilized-metal affinity matrices
AU2676399A (en) Novel cystine knot protein and materials and methods for making it
Roholt et al. A light chain tyrosyl sequence in the antibody site of a rabbit anti-p-azobenzoate antibody
IL96043A (en) Polypeptides having binding affinity for peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known,the binding affinity being dependent on the carboxy-terminal and amino-terminal directionality of the polypeptides
Carrel et al. Studies on sheep anti-human IgG antibodies and their sub-units